In Lviv, at the King Danylo Lviv National Medical University, the Centre for Coordination of Clinical and Preclinical Studies began operating at the end of 2025. The institution aims to streamline the entry of international clinical trials of innovative medicines into Ukraine and to expand patients’ access to cutting-edge therapies.
The article notes that a number of the latest medicines developed by international pharmaceutical companies are extremely expensive. State procurement via the State Enterprise “Medical Procurement of Ukraine” and the National Health Service of Ukraine does not always make it possible to fully meet patients’ needs for such medicines. In these circumstances, participation in international clinical trials becomes, for some patients, a chance to receive “the therapy of the future” today.
The Centre is headed by Anna Kryshchynyn. She leads the Centre for Coordination of Clinical and Preclinical Studies of the King Danylo Lviv National Medical University, is a professor at the university’s Department of Pharmaceutical, Organic and Bioorganic Chemistry, and holds a Doctor of Pharmaceutical Sciences degree.
The article emphasises that the centre does not engage in the full cycle of medicine development in the conventional sense, but instead performs a different role – it creates a reliable, transparent and swift infrastructure for conducting international research in Ukraine. This involves the organisational support of clinical and preclinical trials and the conditions under which patients can join treatment programmes with modern medicines free of charge.
The publication is part of the partner project “This is Med”, implemented jointly with the King Danylo Lviv National Medical University.